Handelsbanken Fonder Ab Regeneron Pharmaceuticals, Inc. Transaction History

Handelsbanken Fonder Ab

$25.3 Billion
Q3 2024

A detailed history of Handelsbanken Fonder Ab transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Handelsbanken Fonder Ab holds 83,640 shares of REGN stock, worth $65.1 Million. This represents 0.35% of its overall portfolio holdings.

Number of Shares

83,640

Previous 87,101 3.97%

Holding current value

$65.1 Million

Previous $91.5 Million 3.95%

% of portfolio

0.35%

Previous 0.4%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 04, 2024	SELL	$1024.09 - $1201.76 $3.54 Million - $4.16 Million	-3,461 Reduced 3.97%	83,640 $87.9 Million
Q2 2024 Aug 05, 2024	SELL	$883.2 - $1071.19 $15.9 Million - $19.3 Million	-18,026 Reduced 17.15%	87,101 $91.5 Million
Q1 2024 May 13, 2024	BUY	$902.69 - $993.35 $9.11 Million - $10 Million	10,087 Added 10.61%	105,127 $101 Million
Q4 2023 Feb 01, 2024	SELL	$775.18 - $881.7 $26.3 Million - $30 Million	-33,986 Reduced 26.34%	95,040 $83.5 Million
Q3 2023 Oct 19, 2023	SELL	$692.45 - $844.37 $3.14 Million - $3.83 Million	-4,532 Reduced 3.39%	129,026 $106 Million
Q2 2023 Aug 02, 2023	SELL	$700.03 - $830.35 $13.1 Million - $15.6 Million	-18,731 Reduced 12.3%	133,558 $96 Million
Q1 2023 Apr 28, 2023	SELL	$680.49 - $826.97 $19.3 Million - $23.4 Million	-28,290 Reduced 15.67%	152,289 $125 Million
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $18.4 Million - $20 Million	-26,041 Reduced 12.6%	180,579 $130 Million
Q3 2022 Oct 27, 2022	BUY	$573.97 - $724.32 $7.06 Million - $8.91 Million	12,300 Added 6.33%	206,620 $142 Million
Q2 2022 Aug 03, 2022	SELL	$548.35 - $738.84 $1.88 Million - $2.53 Million	-3,420 Reduced 1.73%	194,320 $115 Million
Q1 2022 May 11, 2022	BUY	$595.12 - $698.43 $8.33 Million - $9.78 Million	14,000 Added 7.62%	197,740 $138 Million
Q4 2021 Feb 08, 2022	BUY	$543.48 - $670.97 $15.9 Million - $19.7 Million	29,317 Added 18.98%	183,740 $116 Million
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $76.9 Million - $91.2 Million	134,000 Added 656.12%	154,423 $93.5 Million
Q2 2021 Aug 03, 2021	SELL	$472.8 - $558.54 $2.33 Million - $2.76 Million	-4,934 Reduced 19.46%	20,423 $11.4 Million
Q1 2021 Apr 29, 2021	BUY	$446.73 - $548.2 $284,567 - $349,203	637 Added 2.58%	25,357 $12 Million
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $3.49 Million - $4.43 Million	-7,288 Reduced 22.77%	24,720 $11.9 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $7.26 Million - $8.78 Million	-13,335 Reduced 29.41%	32,008 $17.9 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $17.4 Million - $22.8 Million	35,343 Added 353.43%	45,343 $28.3 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $3.36 Million - $4.94 Million	10,000 New	10,000 $4.88 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $83.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Handelsbanken Fonder Ab, based on Form 13F filings with the SEC.

News

Stay updated on Handelsbanken Fonder Ab with notifications on news.

Account

Handelsbanken Fonder Ab Regeneron Pharmaceuticals, Inc. Transaction History